Chronic pulsatile infusion of growth hormone to growth-restricted fetal sheep increases circulating fetal insulin-like growth factor-I levels but not fetal growth

被引:23
作者
Bauer, MK [1 ]
Breier, BB [1 ]
Bloomfield, FH [1 ]
Jensen, EC [1 ]
Gluckman, PD [1 ]
Harding, JE [1 ]
机构
[1] Univ Auckland, Fac Med & Hlth Sci, Liggins Inst, Auckland, New Zealand
关键词
D O I
10.1677/joe.0.1770083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intra-uterine growth restriction (IUGR,) is a major cause of perinatal mortality and morbidity. Postnatally, growth hormone (GH) increases growth, increases circulating insulin-like growth factor (IGF)-I levels, and alters metabolism. Our aim was to determine if GH infusion to IUGR fetal sheep would alter fetal growth and metabolism, and thus provide a potential intra-uterine treatment for the IUGR fetus. We studied three groups of fetuses: control, IUGR+ vehicle and IUGR+GH (n=5 all groups). IUGR was induced by repeated embolisation of the placental vascular bed between 110 and 116 days of gestation (term=145 days). GH (3-5 mg/kg/day) or vehicle was infused in a pulsatile manner from 117 to 127 days of gestation. Embolisation reduced fetal growth rate by 25% (P<0(.)01) and reduced the weight of the fetal liver (20%), kidney (23%) and thymus (31%; all P<0(.)05). GH treatment further reduced the weight of the fetal kidneys (32%) and small intestine (35%; both P<0(.)04), but restored the relative weight of the fetal thymus and liver (P<0(.)05). Embolisation decreased fetal plasma IGF-I concentrations (48%, P<0(.)001) and increased IGF binding protein 1 (IGFBP-1) concentrations (737%, P<0(.)002). GH treatment restored fetal plasma IGF-I concentrations to control levels, while levels in IUGR+vehicle fetuses stayed low (P<0(.)05 vs control). IGFBP-1 and IGFBP-2 concentrations were about sevenfold lower in amniotic fluid than in fetal plasma, but amniotic and plasma concentrations were closely correlated (r=0(.)75, P<0(.)0001 and r=0(.)55 P<0(.)0001 respectively). Embolisation transiently decreased fetal blood oxygen content (40%, P<0(.)002), and increased blood lactate cohcentrations (213%, P<0(.)04). Both returned to pre-embolisation levels after embolisation stopped, but blood glucose concentrations declined steadily in IUGR+vehicle fetuses. GH treatment maintained fetal blood glucose concentrations at control levels. Our study shows that GH infusion to the IUGR fetal sheep restores fetal IGF-I levels but does not improve fetal growth, and further reduces the fetal kidney and intestine weights. Thus, fetal GH therapy does not seem a promising treatment stratagem for the IUGR fetus.
引用
收藏
页码:83 / 92
页数:10
相关论文
共 60 条
  • [31] HORMONE ONTOGENY IN THE OVINE FETUS .3. EFFECT OF EXOGENOUS SOMATOSTATIN
    GLUCKMAN, PD
    MUELLER, PL
    KAPLAN, SL
    RUDOLPH, AM
    GRUMBACH, MM
    [J]. ENDOCRINOLOGY, 1979, 104 (04) : 974 - 978
  • [32] Maternal growth hormone treatment increases placental diffusion capacity but not fetal or placental growth in sheep
    Harding, JE
    Evans, PC
    Gluckman, PD
    [J]. ENDOCRINOLOGY, 1997, 138 (12) : 5352 - 5358
  • [33] INSULIN-LIKE GROWTH-FACTOR-1 ALTERS FETOPLACENTAL PROTEIN AND CARBOHYDRATE-METABOLISM IN FETAL SHEEP
    HARDING, JE
    LIU, L
    EVANS, PC
    GLUCKMAN, PD
    [J]. ENDOCRINOLOGY, 1994, 134 (03) : 1509 - 1514
  • [34] COMPOSITION AND VOLUME OF FLUID SWALLOWED BY FETAL SHEEP
    HARDING, R
    BOCKING, AD
    SIGGER, JN
    WICKHAM, PJD
    [J]. QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY AND COGNATE MEDICAL SCIENCES, 1984, 69 (03): : 487 - 495
  • [35] IWAMOTO HS, 1992, AM J PHYSIOL, V263, pE1151
  • [36] Metabolic effects of IGF-I in the growth retarded fetal sheep
    Jensen, EC
    Harding, JE
    Bauer, MK
    Gluckman, PD
    [J]. JOURNAL OF ENDOCRINOLOGY, 1999, 161 (03) : 485 - 494
  • [37] The role of growth hormone and glucocorticoid in glucose handling in vivo
    Johansen, T
    Deckert, M
    Mandrup-Poulsen, T
    Malmlöf, K
    [J]. JOURNAL OF ENDOCRINOLOGY, 1999, 162 (01) : 87 - 93
  • [38] Enteral IGF-I enhances fetal growth and gastrointestinal development in oesophageal ligated fetal sheep
    Kimble, RM
    Breier, BH
    Gluckman, PD
    Harding, JE
    [J]. JOURNAL OF ENDOCRINOLOGY, 1999, 162 (02) : 227 - 235
  • [39] TISSUE DISTRIBUTION AND ONTOGENY OF GROWTH-HORMONE RECEPTOR MESSENGER-RIBONUCLEIC-ACID AND LIGAND-BINDING TO HEPATIC TISSUE IN THE MIDGESTATION SHEEP FETUS
    KLEMPT, M
    BINGHAM, B
    BREIER, BH
    BAUMBACH, WR
    GLUCKMAN, PD
    [J]. ENDOCRINOLOGY, 1993, 132 (03) : 1071 - 1077
  • [40] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 IS FUNCTIONALLY ALTERED IN PREGNANCY PLASMA
    LASSARRE, C
    BINOUX, M
    [J]. ENDOCRINOLOGY, 1994, 134 (03) : 1254 - 1262